AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

XTL Biopharmaceuticals Ltd.

Regulatory Filings Jun 12, 2008

7116_rns_2008-06-12_5c75a83a-3204-40fb-a70a-856da1c7a710.htm

Regulatory Filings

Open in Viewer

Opens in native device viewer

_________ false

C002��� �� �� ������������� ��"�2PublicX T L BIOPHARMACEUTICALS LTD4313Corporation no: 520039470Stock Exchange/Market: ��� �� ��1996380Hasapir 3 , Nes Ziona 76100 , ,Tel: 08-9304444 , Fax: 08-9304445E.mail address: [email protected] of transmission: 12/06/2008              Time of broadcast: 20:32 20:25:54

Reference: 2008-02-166377

Israel Securities Authority Tel Aviv Stock Exchange
www.isa.gov.il www.tase.co.il

Immediate ReportRegulation 4 of the Securities Regulations, (Periodic and Immediate Reports of Foreign Corporation) 5761-2000

The corporation is a foreign private issuer as defined by U.S. Securities Laws.
Attached hereto is a report on Notification of amendment to Record Date for the Annual General Meeting and Extraordinary General Meeting
AGMannouncementRecordDate02_isa.pdf
This amends the Company's reports regarding the Annual & Extraordinary General Meetings (References-2008-02-165198 & 2008-02-165240 respectively) reported earlier today.
References of previous documents relating to this matter(the reference does not constitute incorporation by reference):
Previous names of reporting entity: XENOGRAFT TECHNOLOGIES LTD
Date of revision of form structure: 30/04/2008
- - -
Name of the Signatory: : Kantor Ronen , Position of Signatory in the reporting corporation: Legal Consultant & Corporate Secretary , Name of Employer Company: .
Abba Hillel Silver Telephone: 03-6133371 , Facsimile: 03-6133372 , E-mail: [email protected] 2

Talk to a Data Expert

Have a question? We'll get back to you promptly.